ask="14.75"
ask_size="300"
average_daily_volume="102065"
bid="11.72"
bid_size="400"
book_value="5.16"
change="+0.25"
change_from_200_day_moving_average="0.53"
change_from_50_day_moving_average="2.71"
change_from_52_week_high="-6.40"
change_From_52_week_low="5.32"
change_in_percent="+2.20%"
close="11.63"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.47"
ebitda="-31.93M"
eps_estimate_current_year="-3.59"
eps_estimate_next_quarter="-0.72"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="12136000"
high="12.00"
high_52_weeks="18.03"
last_trade_date="3/1/2017"
last_trade_price="11.63"
last_trade_size="2209"
last_trade_time="4:00pm"
low="10.98"
low_52_weeks="6.31"
market_capitalization="211.58M"
moving_average_200_day="11.10"
moving_average_50_day="8.92"
name="Syndax Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.83"
open="11.74"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+4.80%"
percent_change_from_50_day_moving_average="+30.36%"
percent_change_from_52_week_high="-35.50%"
percent_change_from_52_week_low="+84.27%"
previous_close="11.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.20"
price_per_sales="169.70"
revenue="1.22M"
shares_outstanding="18193000"
short_ratio="1.87"
stock_exchange="NMS"
symbol="SNDX"
volume="118708"
weeks_range_52="6.31 - 18.03"
